CNTX Context Therapeutics Inc
Company Analysis
Latest News
🔴 Context Therapeutics Inc is trading 11.4% down today amid a broad biotech selloff and hawkish rate expectations
Context Therapeutics Inc is trading 11.4% down at $2.00 following a sharp session decline driven by a broad market selloff rather than company-specific...
🔴 Context Therapeutics Inc is trading 10.84% down today amid broader market pressure and hawkish rate expectations
Context Therapeutics Inc is trading 10.84% down at $1.81 as broader market pressure weighs heavily on the biotechnology sector. • The move appears tied to a...
🔴 Context Therapeutics Inc is trading 5.2% down today amid broader biotech sector weakness
Context Therapeutics Inc is trading 5.2% down at $1.93 today as the stock continues a multi-day slide amid broader risk-off pressure hitting growth and...
🟢 Context Therapeutics Inc is trading 7.1% up today on a technical bounce after consecutive double-digit declines
Context Therapeutics Inc is trading up 7.1% at $2.19 as traders position for a short-term rebound following a period of heavy selling. • The move comes after...
🟢 Context Therapeutics Inc is trading 6.8% up today on a potential technical bounce after recent declines
Context Therapeutics Inc is trading 6.8% up today at $2.19 as the stock appears to be staging a technical bounce or attracting bargain hunters following two...
🔴 Context Therapeutics Inc is trading 10.9% down today as traders lock in profits after recent rally
Context Therapeutics Inc is trading 10.9% down at $2.48 as investors lock in gains following a sharp multi-day rally. • The stock recently surged from...
🔴 Context Therapeutics Inc is trading 6.3% down today as traders take profits following a multi-day rally
Context Therapeutics Inc is trading 6.3% down at $2.62 as the stock pulls back from a recent multi-day rally that saw prices rise from approximately $2.40. •...
🔴 Context Therapeutics Inc is trading 6.3% down today as it gives back recent gains
Context Therapeutics Inc is trading 6.3% down at $2.62 as the stock gives back a portion of its recent gains following a strong rally. • The decline follows a...